Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2011 (2011), Article ID 124078, 5 pages
http://dx.doi.org/10.1155/2011/124078
Case Report

Metastatic Insulinoma in a Patient with Type 2 Diabetes Mellitus: Case Report and Review of the Literature

1Department of Endocrinology, St. James' Hospital, Dublin 8, Ireland
2Department of Endocrinology, St. Vincent's University Hospital, Dublin 4, Ireland
3Department of Surgery, St. Vincent's University Hospital, Dublin 4, Ireland
4Department of Pathology, St. James' Hospital, Dublin 8, Ireland
5Department of Pathology, St. Vincent's University Hospital, Dublin 4, Ireland
6Department of Gastroenterology, St. James' Hospital, Dublin 8, Ireland

Received 3 November 2010; Accepted 5 January 2011

Academic Editor: A. L. Barkan

Copyright © 2011 Noormuhammad Oosman Abbasakoor et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. J. Service, M. M. McMahon, P. C. O'Brien, and D. J. Ballard, “Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study,” Mayo Clinic Proceedings, vol. 66, no. 7, pp. 711–719, 1991. View at Google Scholar
  2. M. Ozkaya, M. F. Yuzbasioglu, I. Koruk et al., “Islet cell tumors of the pancreas: the medical oncologist's perspective,” Cases Journal, vol. 1, article 362, 2008. View at Google Scholar
  3. R. Brentjens and L. Saltz, “Islet cell tumors of the pancreas: the medical oncologist's perspective,” Surgical Clinics of North America, vol. 81, no. 3, pp. 527–542, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. M. P. Boukhman, J. H. Karam, J. Shaver, A. E. Siperstein, Q. Y. Duh, and O. H. Clark, “Insulinoma—experience from 1950 to 1995,” Western Journal of Medicine, vol. 169, no. 2, pp. 98–104, 1998. View at Google Scholar · View at Scopus
  5. G. Rindi, G. Klöppel, H. Alhman et al., “TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system,” Virchows Archiv, vol. 449, no. 4, pp. 395–401, 2006. View at Publisher · View at Google Scholar · View at PubMed
  6. C. Toyoda, K. Hosokawa, Y. Atsumi et al., “Malignant insulinoma with extensive liver metastases presenting as disturbance of consciousness,” Internal Medicine, vol. 37, no. 5, pp. 476–479, 1998. View at Google Scholar · View at Scopus
  7. M. Alison, “Endoscopic ultrasound in the detection of pancreatic islet cell tumours,” Cancer Imaging, vol. 4, pp. 84–91, 2004. View at Google Scholar
  8. W. W. de Herder, B. Niederle, J.-Y. Scoazec et al., “Well-differentiated pancreatic tumour/carcinoma: insulinoma,” Neuroendocrinology, vol. 84, pp. 183–188, 2006. View at Google Scholar
  9. D. Vezzosi, A. Bennet, P. Rochaix et al., “Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies,” European Journal of Endocrinology, vol. 152, no. 5, pp. 757–767, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. E. P. Krenning, D. J. Kwekkeboom, W. H. Bakker et al., “Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the rotterdam experience with more than 1000 patients,” European Journal of Nuclear Medicine, vol. 20, no. 8, pp. 716–731, 1993. View at Google Scholar
  11. J. Bertherat, F. Tenenbaum, K. Perlemoine et al., “Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 11, pp. 5353–5360, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Y. Lei, T. E. Wang, T. L. Chen, W. H. Chang, T. L. Yang, and C. Y. Wang, “Insulinoma causing hypoglycemia in a patient with type 2 diabetes,” Journal of the Formosan Medical Association, vol. 106, no. 5, pp. 392–396, 2007. View at Google Scholar · View at Scopus
  13. L. A. Kane, C. S. Grant, T. B. Nippoldt, and F. J. Service, “Insulinoma in a patient with NIDDM,” Diabetes Care, vol. 16, no. 9, pp. 1298–1300, 1993. View at Google Scholar · View at Scopus
  14. H. Ishii, T. Ito, S. Moriya, Y. Horie, and M. Tsuchiya, “Insulinoma—a statistical review of 443 cases in Japan,” Nippon Rinsho, vol. 51, supplement, pp. 199–206, 1993. View at Google Scholar · View at Scopus
  15. B. E. Stabile, “Islet cell tumors,” Gastroenterologist, vol. 5, no. 3, pp. 213–232, 1997. View at Google Scholar · View at Scopus
  16. G. V. Gill, O. Rauf, and I. A. MacFarlane, “Diazoxide treatment for insulinoma: a national UK survey,” Postgraduate Medical Journal, vol. 73, no. 864, pp. 640–641, 1997. View at Google Scholar · View at Scopus
  17. L. Moscetti, R. Saltarelli, R. Giuliani, G. Fornarini, M. Bezzi, and E. Cortesi, “Intra-arterial liver chemotherapy and hormone therapy in malignant insulinoma: case report and review of the literature,” Tumori, vol. 86, no. 6, pp. 475–479, 2000. View at Google Scholar · View at Scopus
  18. M. H. Kulke, E. K. Bergsland, and J. C. Yao, “Glycemic control in patients with insulinoma treated with everolimus,” The New England Journal of Medicine, vol. 360, no. 2, pp. 195–197, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. G. S. Y. Ong, D. E. Henley, D. Hurley, J. H. Turner, P. G. Claringbold, and P. G. Fegan, “Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma,” European Journal of Endocrinology, vol. 162, no. 5, pp. 1001–1008, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. H. Liu, S.-Z. Zhang, Y.-L. Wu et al., “Diagnosis and surgical treatment of pancreatic endocrine tumors in 36 patients: a single-center report,” Chinese Medical Journal, vol. 120, no. 17, pp. 1487–1490, 2007. View at Google Scholar
  21. R. Kianmanesh, A. Sauvanet, O. Hentic et al., “Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: a safe approach for radical resection,” Annals of Surgery, vol. 247, no. 4, pp. 659–665, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. D. N. Danforth Jr., P. Gorden, and M. F. Brennan, “Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery,” Surgery, vol. 96, no. 6, pp. 1027–1036, 1984. View at Google Scholar · View at Scopus
  23. A. Begu-Le Corroller, R. Valero, V. Moutardier et al., “Aggressive multimodal therapy of sporadic malignant insulinoma can improve survival: a retrospective 35-year study of 12 patients,” Diabetes and Metabolism, vol. 34, no. 4, pp. 343–348, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. D. J. Kwekkeboom, J. J. Teunissen, W. H. Bakker et al., “Radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors,” Journal of Clinical Oncology, vol. 23, no. 12, pp. 2754–2762, 2005. View at Publisher · View at Google Scholar · View at PubMed
  25. Q. D. Chu, H. C. Hill, H. O. Douglas Jr. et al., “Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the gastrointestinal tract,” Quarterly Journal of Nuclear Medicine, vol. 44, pp. 13–21, 2000. View at Google Scholar